Odontoprev, trading under the symbol ODPV3, reported on Monday, April 6, that its shareholders have approved a business combination with Bradesco Gestão de Saúde (BGS). The decision was made during a shareholder assembly held on that date.
The merger involves the incorporation of shares, which will grant a withdrawal right to Odontoprev investors who dissent from the deal. The company stated that the deadline for exercising this right will be announced at a later time.
In a material fact disclosure, Odontoprev confirmed that all suspensive conditions for the transaction have been properly verified. This includes receiving the necessary authorizations from the National Supplementary Health Agency (ANS). The ANS approved the share incorporation on March 30, 2026, and the asset contribution on April 2, 2026.
The share incorporation was authorized on April 2, 2026. The process must be completed by the final deadline of April 30, 2026.
Odontoprev also informed that it is formalizing a change to its trading code with the B3 stock exchange. The current ticker, ODPV3, will be replaced by the new ticker, SAUD3.
This business combination between Odontoprev and Bradesco Gestão de Saúde represents a consolidation in the health services market. The completion of the merger is contingent upon meeting the established deadlines and fulfilling all regulatory requirements as outlined in the company’s disclosures.
- Brazil’s Oncoclínicas (ONCO3) Board Chairman Quits - abril 7, 2026
- Brazil stocks, dollar and corporate news in focus - abril 7, 2026
- Brazil’s Rede D’or Pays Shareholder Payout Today - abril 7, 2026
